Literature DB >> 21804994

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery.

Martin Philpott1, Jing Yang, Tony Tumber, Oleg Fedorov, Sagar Uttarkar, Panagis Filippakopoulos, Sarah Picaud, Tracy Keates, Ildiko Felletar, Alessio Ciulli, Stefan Knapp, Tom D Heightman.   

Abstract

Histone lysine acetylation is a key component of epigenetic regulation of gene transcription. Bromodomains, found in histone acetyl transferases and other chromatin-associated proteins, bind selectively to acetylated lysines, acting as "readers" of the histone code, and have recently been shown to contain a druggable binding pocket. Here we report the development of high-throughput assays that quantify the binding of bromodomains to acetylated histone peptides. We have used these assays to screen for histone binding partners of as yet uncharacterized bromodomains, adding to current knowledge of the histone code and expanding the repertoire of assays for chemical probe discovery. We have also demonstrated that these assays can be used to detect small molecule binding from the very weak to the nanomolar range. This assay methodology is thereby anticipated to provide the basis both for broader interactome profiling and for small molecule inhibitor discovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21804994     DOI: 10.1039/c1mb05099k

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  53 in total

1.  NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex.

Authors:  Noelle M Olson; Samantha Kroc; Jorden A Johnson; Huda Zahid; Peter D Ycas; Alice Chan; Jennifer R Kimbrough; Prakriti Kalra; Ernst Schönbrunn; William C K Pomerantz
Journal:  Biochemistry       Date:  2020-05-11       Impact factor: 3.162

2.  Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules.

Authors:  Jian Zhu; Jing Dong; Laurent Batiste; Andrea Unzue; Aymeric Dolbois; Vlad Pascanu; Paweł Śledź; Cristina Nevado; Amedeo Caflisch
Journal:  ACS Med Chem Lett       Date:  2018-08-08       Impact factor: 4.345

3.  Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay.

Authors:  Zhifeng Chen; Hao Zhang; Shien Liu; Yiqian Xie; Hao Jiang; Wenchao Lu; Heng Xu; Liyan Yue; Yuanyuan Zhang; Hong Ding; Mingyue Zheng; Kunqian Yu; Kaixian Chen; Hualiang Jiang; Cheng Luo
Journal:  Medchemcomm       Date:  2017-03-17       Impact factor: 3.597

4.  Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.

Authors:  Wylie S Palmer; Guillaume Poncet-Montange; Gang Liu; Alessia Petrocchi; Naphtali Reyna; Govindan Subramanian; Jay Theroff; Anne Yau; Maria Kost-Alimova; Jennifer P Bardenhagen; Elisabetta Leo; Hannah E Shepard; Trang N Tieu; Xi Shi; Yanai Zhan; Shuping Zhao; Michelle C Barton; Giulio Draetta; Carlo Toniatti; Philip Jones; Mary Geck Do; Jannik N Andersen
Journal:  J Med Chem       Date:  2015-07-06       Impact factor: 7.446

5.  Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.

Authors:  Tian Lu; Jun-Chi Hu; Wen-Chao Lu; Jie Han; Hong Ding; Hao Jiang; Yuan-Yuan Zhang; Li-Yan Yue; Shi-Jie Chen; Hua-Liang Jiang; Kai-Xian Chen; Hui-Fang Chai; Cheng Luo
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

6.  BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.

Authors:  Alex M Ayoub; Laura M L Hawk; Ryan J Herzig; Jiewei Jiang; Andrea J Wisniewski; Clifford T Gee; Peiliang Zhao; Jin-Yi Zhu; Norbert Berndt; Nana K Offei-Addo; Thomas G Scott; Jun Qi; James E Bradner; Timothy R Ward; Ernst Schönbrunn; Gunda I Georg; William C K Pomerantz
Journal:  J Med Chem       Date:  2017-06-07       Impact factor: 7.446

7.  BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.

Authors:  Ballachanda N Devaiah; Brian A Lewis; Natasha Cherman; Michael C Hewitt; Brian K Albrecht; Pamela G Robey; Keiko Ozato; Robert J Sims; Dinah S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

8.  BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.

Authors:  Tiana M Scott; Hui Guo; Evan E Eichler; Jill A Rosenfeld; Kaifang Pang; Zhandong Liu; Seema Lalani; Weimin Bi; Yaping Yang; Carlos A Bacino; Haley Streff; Andrea M Lewis; Mary K Koenig; Isabelle Thiffault; Allison Bellomo; David B Everman; Julie R Jones; Roger E Stevenson; Raphael Bernier; Christian Gilissen; Rolph Pfundt; Susan M Hiatt; Gregory M Cooper; Jimmy L Holder; Daryl A Scott
Journal:  Hum Mutat       Date:  2020-02-07       Impact factor: 4.878

9.  Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2.

Authors:  Guillaume Poncet-Montange; Yanai Zhan; Jennifer P Bardenhagen; Alessia Petrocchi; Elisabetta Leo; Xi Shi; Gilbert R Lee; Paul G Leonard; Mary K Geck Do; Mario G Cardozo; Jannik N Andersen; Wylie S Palmer; Philip Jones; John E Ladbury
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

10.  Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules.

Authors:  Andrew K Urick; Laura M L Hawk; Melissa K Cassel; Neeraj K Mishra; Shuai Liu; Neeta Adhikari; Wei Zhang; Camila O dos Santos; Jennifer L Hall; William C K Pomerantz
Journal:  ACS Chem Biol       Date:  2015-07-28       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.